Heyang Cui

1.9k total citations
20 papers, 250 citations indexed

About

Heyang Cui is a scholar working on Molecular Biology, Oncology and Cell Biology. According to data from OpenAlex, Heyang Cui has authored 20 papers receiving a total of 250 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 7 papers in Oncology and 6 papers in Cell Biology. Recurrent topics in Heyang Cui's work include RNA modifications and cancer (7 papers), Cellular Mechanics and Interactions (4 papers) and Cancer-related gene regulation (4 papers). Heyang Cui is often cited by papers focused on RNA modifications and cancer (7 papers), Cellular Mechanics and Interactions (4 papers) and Cancer-related gene regulation (4 papers). Heyang Cui collaborates with scholars based in China, Hong Kong and United States. Heyang Cui's co-authors include Yongping Cui, Pengzhou Kong, Yanghui Bi, Yikun Cheng, Yu Qian, Ting Yan, Xiaolong Cheng, Ling Zhang, Yanchun Ma and Shiping Guo and has published in prestigious journals such as Oncogene, Cancer Letters and Signal Transduction and Targeted Therapy.

In The Last Decade

Heyang Cui

17 papers receiving 250 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Heyang Cui China 11 178 78 57 39 38 20 250
G Selvaluxmy India 7 176 1.0× 79 1.0× 88 1.5× 20 0.5× 42 1.1× 11 274
Thi Bich Uyen Le Singapore 9 268 1.5× 63 0.8× 64 1.1× 18 0.5× 27 0.7× 11 336
Soo Been Park South Korea 10 185 1.0× 144 1.8× 94 1.6× 19 0.5× 36 0.9× 17 306
Tonći Šuštić Netherlands 7 192 1.1× 72 0.9× 53 0.9× 13 0.3× 54 1.4× 9 255
Ольга Викторовна Николаева Russia 4 128 0.7× 68 0.9× 53 0.9× 56 1.4× 27 0.7× 10 314
Zhangwei Tong China 9 235 1.3× 90 1.2× 106 1.9× 17 0.4× 35 0.9× 17 347
Shiho Fujiwara Japan 8 195 1.1× 130 1.7× 51 0.9× 21 0.5× 15 0.4× 16 323
Laia Vilà Spain 8 183 1.0× 168 2.2× 49 0.9× 19 0.5× 86 2.3× 20 325
Ellen S. Hong United States 6 121 0.7× 77 1.0× 58 1.0× 29 0.7× 67 1.8× 11 219
Chunfang Ha China 9 160 0.9× 76 1.0× 117 2.1× 29 0.7× 23 0.6× 25 308

Countries citing papers authored by Heyang Cui

Since Specialization
Citations

This map shows the geographic impact of Heyang Cui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Heyang Cui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Heyang Cui more than expected).

Fields of papers citing papers by Heyang Cui

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Heyang Cui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Heyang Cui. The network helps show where Heyang Cui may publish in the future.

Co-authorship network of co-authors of Heyang Cui

This figure shows the co-authorship network connecting the top 25 collaborators of Heyang Cui. A scholar is included among the top collaborators of Heyang Cui based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Heyang Cui. Heyang Cui is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
3.
Gao, Mingwei, Xuehan Zhuang, Yueguang Wu, et al.. (2025). Evolutionary adaptation and asymmetric inheritance of polyploid giant cancer cells in esophageal squamous cell carcinoma. Cancer Letters. 630. 217818–217818. 4 indexed citations
4.
Zhuang, Xuehan, Rui Ye, Yong Zhou, et al.. (2024). Leveraging new methods for comprehensive characterization of mitochondrial DNA in esophageal squamous cell carcinoma. Genome Medicine. 16(1). 50–50. 4 indexed citations
5.
Wu, Yueguang, Ning Ding, Yan Zhou, et al.. (2024). Three-dimensional characteristics of T cells and vasculature in the development of mouse esophageal cancer. iScience. 27(12). 111380–111380.
6.
Zhao, Yahui, Yang Li, Rui Zhu, et al.. (2023). RPS15 interacted with IGF2BP1 to promote esophageal squamous cell carcinoma development via recognizing m6A modification. Signal Transduction and Targeted Therapy. 8(1). 224–224. 28 indexed citations
7.
Wang, Longlong, Yong Zhou, Heyang Cui, et al.. (2023). IGH repertoire analysis at scale: deciphering the complexity of B cell infiltration and migration in esophageal squamous cell carcinoma. Cancer Gene Therapy. 31(1). 131–147. 1 indexed citations
8.
Ding, Ning, Yikun Cheng, Huijuan Liu, et al.. (2023). Fusobacterium nucleatum Infection Induces Malignant Proliferation of Esophageal Squamous Cell Carcinoma Cell by Putrescine Production. Microbiology Spectrum. 11(2). e0275922–e0275922. 17 indexed citations
9.
Yang, Xin, Heyang Cui, Yanchun Ma, et al.. (2022). An N-glycoproteomic site-mapping analysis reveals glycoprotein alterations in esophageal squamous cell carcinoma. Journal of Translational Medicine. 20(1). 285–285. 10 indexed citations
10.
Chen, Cheng, Heyang Cui, Huijuan Liu, et al.. (2022). Role of Epidermal Growth Factor Receptor-Specific CAR-T Cells in the Suppression of Esophageal Squamous Cell Carcinoma. Cancers. 14(24). 6021–6021. 1 indexed citations
11.
Cui, Heyang, Ning Ding, Cheng Chen, et al.. (2021). Autophagy-Related Three-Gene Prognostic Signature for Predicting Survival in Esophageal Squamous Cell Carcinoma. Frontiers in Oncology. 11. 650891–650891. 9 indexed citations
12.
Li, Hongyi, Shaojie Wang, Fang Wang, et al.. (2021). CDCA7 Facilitates Tumor Progression by Directly Regulating CCNA2 Expression in Esophageal Squamous Cell Carcinoma. Frontiers in Oncology. 11. 734655–734655. 14 indexed citations
13.
Qian, Yu, Pengzhou Kong, Yikun Cheng, et al.. (2020). Elevated DHODH expression promotes cell proliferation via stabilizing β-catenin in esophageal squamous cell carcinoma. Cell Death and Disease. 11(10). 862–862. 28 indexed citations
14.
Kong, Pengzhou, Enwei Xu, Yanghui Bi, et al.. (2020). Novel ESCC-related gene ZNF750 as potential Prognostic biomarker and inhibits Epithelial-Mesenchymal Transition through directly depressing SNAI1 promoter in ESCC. Theranostics. 10(4). 1798–1813. 28 indexed citations
15.
Zhang, Ling, Xiaojuan Zhang, Min Guo, et al.. (2020). TSTA3 facilitates esophageal squamous cell carcinoma progression through regulating fucosylation of LAMP2 and ERBB2. Theranostics. 10(24). 11339–11358. 19 indexed citations
16.
Zhang, Ling, et al.. (2020). Potential Role of Targeting KDR and Proteasome Inhibitors in the Therapy of Esophageal Squamous Cell Carcinoma. Technology in Cancer Research & Treatment. 19. 1079215708–1079215708. 2 indexed citations
17.
Hu, Xiao, Yuanfang Zhai, Ruyi Shi, et al.. (2018). FAT1 inhibits cell migration and invasion by affecting cellular mechanical properties in esophageal squamous cell carcinoma. Oncology Reports. 39(5). 2136–2146. 23 indexed citations
18.
Shi, Ruyi, Heyang Cui, Yanghui Bi, et al.. (2015). Artesunate altered cellular mechanical properties leading to deregulation of cell proliferation and migration in esophageal squamous cell carcinoma. Oncology Letters. 9(5). 2249–2255. 20 indexed citations
19.
Zhang, Ling, Ruyi Shi, Caixia Cheng, et al.. (2013). Oncogenic B-RafV600E abrogates the AKT/B-Raf/Mps1 interaction in melanoma cells. Cancer Letters. 337(1). 125–132. 14 indexed citations
20.
Cheng, Xiaolong, Heyang Cui, Zhenxiang Zhao, et al.. (2012). Phosphorylation of Mps1 by BRAFV600E prevents Mps1 degradation and contributes to chromosome instability in melanoma. Oncogene. 32(6). 713–723. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026